Learn more

HYBRIGENICS SA

Overview
  • Total Patents
    153
  • GoodIP Patent Rank
    169,387
  • Filing trend
    ⇩ 100.0%
About

HYBRIGENICS SA has a total of 153 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are LINK MEDICINE CORP, ACHE LAB FARMACEUTICOS SA and METABOLIC SOLUTIONS DEV CO.

Patent filings per year

Chart showing HYBRIGENICS SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Colland Frederic 46
#2 Delansorne Remi 44
#3 Rain Jean-Christophe 39
#4 Daviet Laurent 34
#5 Legrain Pierre 33
#6 Jacq Xavier 28
#7 Formstecher Etienne 28
#8 Guedat Philippe 28
#9 Colombo Matteo 19
#10 Borg-Capra Catherine 18

Latest patents

Publication Filing date Title
EP3487506A1 Combinations of inecalcitol with an anti-cd38 agent and their uses for treating cancer
EP2565186A1 Selective and reversible inhibitors of ubiquitin specific protease 7
AU2011278346A1 New formulations of 14 - epi -analogues of vitamin D
UA110211C2 New storage 14-ei-vitamin d analogues
EP2357176A1 Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
EP2407152A1 Formulations of 14-epi-analogues of vitamin D
AU2010261967A1 New therapeutical uses of inecalcitol
EP2360145A1 New process for isomerizing fused bicyclic structures and preparation of vitamin D analogs comprising the same
EP2208725A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications
AU2007315885A1 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
EP1808493A2 Substrates and methods for assaying deubiquitinating enzymes activity
MX2008007195A Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications.
EP1918292A1 Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
US2008103149A1 Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
AU2006277678A1 Novel cysteine protease inhibitors and their therapeutic applications
EP1798232A1 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
US2007135439A1 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
EP1749822A1 Novel cysteine protease inhibitors and their therapeutic applications
AU2003225506A1 Method for organizing and querying genomic and proteomic databases
AU2002365517A1 Protein-protein interactions involving transforming growth factor beta signalling